No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naïve HIV Patients-Reference-Cited by-同舟云学术

No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naïve HIV Patients

Published:2018 Issue:6 Volume:61 Page:281-291
ISSN:0300-5526
Container-title:Intervirology
language:en
Short-container-title:Intervirology

Author:

Chen Rongfeng,Liang Bingyu,Wen Binbin,Huang Guanghua,Ning Chuanyi,Lao Chengyong,Jiang Junjun,Liu Jie,Zhou Bo ,Huang Jiegang,Chen Jinmei,Zang Ning,Liao Yanyan,Mo Dongsong,Ye Li,Liang Hao

Publisher

S. Karger AG

Subject

Infectious Diseases,Virology

Reference48 articles.

1. Vella S, Schwartländer B, Sow SP, Eholie SP, Murphy RL. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS. 2012 Jun;26(10):1231–41.

2. Phillips AN, Cambiano V, Miners A, Revill P, Pillay D, Lundgren JD, et al. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. Lancet HIV. 2014 Nov;1(2):e85–93.

3. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al.; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov;372(9651):1733–45.

4. Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, et al. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. AIDS. 2000 Jan;14(2):F17–23.

5. Kozal MJ, Amico KR, Chiarella J, Schreibman T, Cornman D, Fisher W, et al. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004 Nov;18(16):2185–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The origin, dissemination, and molecular networks of HIV-1 CRF65_cpx strain in Hainan Island, China;BMC Infectious Diseases;2024-03-01

2. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020*;BIOMED ENVIRON SCI;2023

3. Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China;Emerging Microbes & Infections;2022-12-28

4. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China;AIDS Research and Human Retroviruses;2022-10-01

5. Prevalence and Molecular Epidemiology of Transmitted Drug Resistance and Genetic Transmission Networks Among Newly Diagnosed People Living With HIV/AIDS in a Minority Area, China;Frontiers in Public Health;2021-10-11